Question: Which pharmacologic classes are specifically recommended in the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome? Need Assignment Help? A. GLP-1 agonists and flutamide B. Orlistat and metformin C. GLP-1 agonists and metformin D. GLP-1 agonists and orlistat